UCB launches Eu2bn refi facility
Belgian biopharma group UCB has launched a Eu2bn loan to refinance part of the debt it took on to buy German rival Schwarz Pharma in 2006.
The facility is split into a Eu500m 364 day term loan and a Eu1.5bn three year revolver with an optional one year extension. The deal is being co-ordinated by BNP Paribas Fortis, Commerzbank and Mizuho.
The loan will partly refinance a Eu4bn acquisition facility taken out by UCB ...Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: subs@globalcapital.com
Or sign up for a trial to gain full access to the entire site for a limited period.
Corporate access
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.
